Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 17, 2022

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
Multiple MyelomaRefractory Multiple Myeloma
Interventions
BEHAVIORAL

Digital Health Coaching Program

consisting of weekly calls and delivery of evidence-based content across health and wellness domains (e.g. nutrition, exercise, physical, emotional and financial health) up to 4 times weekly via text, email or mobile application.

DEVICE

Fitbit

A wrist-worn activity tracker allowing for the capture of physical activity, including but not limited to step-count and minutes of activity, to be captured daily.

Trial Locations (2)

77074

ACTIVE_NOT_RECRUITING

The University of Texas MD Anderson Cancer Center, Houston

98109

RECRUITING

University of Washington, Seattle

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Sanofi

INDUSTRY

collaborator

University of Washington

OTHER

lead

Pack Health

INDUSTRY